Celregen Therapeutics Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 2

Celregen Therapeutics General Information

Description

Provider of platform-based solutions designed for cell therapy and regenerative medicine. The company focuses on building advanced technologies, including rapid iPSC reprogramming, a patented CRISPR/Cas12b-based iPSC gene-editing platform, and bioinformatics-guided differentiation techniques across different germ layers, providing comprehensive upstream and downstream R&D processes for iPSCs and their derivative products.

Contact Information

Website
www.celregen.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3rd Floor, Building 2, No. 367, Shengrong Road
  • Zhangjiang Town, Pudong New Area
  • Shanghai
  • China
+86 021
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 3rd Floor, Building 2, No. 367, Shengrong Road
  • Zhangjiang Town, Pudong New Area
  • Shanghai
  • China
+86 021

Celregen Therapeutics Timeline

2023202420252026
Date FoundedFinancing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Celregen Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 18-Mar-2025 Completed Pre-Clinical Trials
2. Early Stage VC 14-Sep-2024 Completed Pre-Clinical Trials
1. Seed Round 05-Aug-2022 $6.67M $6.67M Completed Startup
To view Celregen Therapeutics’s complete valuation and funding history, request access »

Celregen Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Shanghai Creation Investment Management Venture Capital Minority
Fosun Health Capital Corporate Venture Capital Minority
To view Celregen Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Celregen Therapeutics FAQs

  • When was Celregen Therapeutics founded?

    Celregen Therapeutics was founded in 2022.

  • Where is Celregen Therapeutics headquartered?

    Celregen Therapeutics is headquartered in Shanghai, China.

  • What industry is Celregen Therapeutics in?

    Celregen Therapeutics’s primary industry is Drug Discovery.

  • Is Celregen Therapeutics a private or public company?

    Celregen Therapeutics is a Private company.

  • What is Celregen Therapeutics’s current revenue?

    The current revenue for Celregen Therapeutics is .

  • How much funding has Celregen Therapeutics raised over time?

    Celregen Therapeutics has raised $6.67M.

  • Who are Celregen Therapeutics’s investors?

    Shanghai Creation Investment Management and Fosun Health Capital have invested in Celregen Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process